GE Healthcare and Arineta Ltd Announce Partnership to Tackle Cardiovascular Disease

GE HealthcareGE Healthcare, a unit of General Electric Company (NYSE: GE), and Arineta Ltd. announced the formation of a strategic partnership in the area of computed tomography (CT) for cardiovascular applications.

Cardiovascular disease (CVD) continues to be the leading cause of death globally and has an enormous impact on public health and the healthcare delivery system. The goal of the partnership between the two companies is to develop solutions that will address this global challenge by improving the cost, access to and the quality of cardiac care.

"CT can be a viable, minimally-invasive imaging alternative for many cardiovascular procedures," said Steve Gray, VP and General Manager for GE Healthcare Global CT and Advantage Workstation. "We chose Arineta as a partner because we believe their cardiovascular imaging technology complements the GE Healthcare market-leading position in CT imaging."

Yosi Morik, Arineta co-founder and Chairman commented "We believe this collaboration with GE Healthcare provides the most effective path for Arineta to bring its cardiovascular imaging technologies to market."

Related news articles:

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $16 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

About Arineta Ltd
Arineta Ltd., based in Caesarea, Israel, is a privately owned start-up company focused on the development of advanced imaging systems for cardiovascular diagnosis and therapeutic applications. Arineta's mission is to develop clinically effective, reliable and safe solutions for cardiovascular imaging. Arineta systems are being developed to provide clear, sharp and accurate images - while optimizing dose, reducing discomfort to the patient, and lowering the cost of healthcare delivery. For more information about Arineta, see www.arineta.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...